| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 95448 | 1H-1,2,4-Triazole, 3-(4-diazo-4H-imidazol-5-yl)- | 0.00010455364200097 | 0.64248659 |
| NSC 665076 | 1,3-butadiene, 1,1,2,4,4-pentachloro-3-nitro- | 0.000141616984257996 | 0.35397518 |
| NSC 648265 | [3-keto-Bmt(sup 1)]-[Val(sup 2)]-Cyclosporin | 0.000150163566228977 | 0.059042199 |
| NSC 619837 | Null | 0.000152553454647253 | 0.26324949 |
| NSC 657270 | (+/-) Ethyl trans-2-(3,4-dihydroxyphenyl) cyclopropane-carboxylate | 0.000174252554411806 | 0.24193892 |
| NSC 637693 | Ethanedioic acid, mono(4,9-dihydro-4,9-dioxonaphtho[2,3-d]thiazol-2-yl)hydrazide, monoethyl ester | 0.000176661849797006 | 0.36738351 |
| NSC 654236 | Null | 0.000176661849797006 | 0.40853468 |
| NSC 658142 | 2-(1-(4-(2-Pyridyl)piperazino))naphthazarin | 0.000176661849797006 | 0.29487692 |
| NSC 702415 | Null | 0.000416054125944642 | 0.21643549 |
| NSC 700087 | Bisoxireno[1,10a:3,4]phenanthro[3,2-b]furan-9(7aH)-one, 1,2, 3,4,4a,5,6,11a,11b,11c-decahydro-4,4,8,11c-tetramethyl-, [4aR-(4a.alpha.,6aS*,7a.beta.,10aR*,11a.beta.,11b.alpha.,11c.beta,)]- (9CI) | 0.000455867606843417 | 0.28917079 |